Recommendations for Urological cancers During COVID19 Pandemic
We are all immersed with COVID19 as to Doâ€™s and Donâ€™ts Concerning Urological Disorders. AUA and few other organizations have produced Guidelines concerning this and these have been circulated and discussed in the two Webinars organized by USI.
The treatment for Urological Disorders is classified into three categories namely Delayed, Not so delayed and Emergency.
Urological Cancers, as are many diseases, do not wait for COVID19 to abate. These patients with or without COVID19 surfaces for treatment and it is our duty to adequately treat them irrespective of the Pandemic.
We are informed that certain procedures can be accepted for certain cancers depending on the stage of Presentation. I am providing an article with a table incorporated below on the recommendations to be followed regarding â€˜Systemic Therapy in Patients with Urological Cancers during the COVID19 Pandemicâ€™.
World over, with India no exception of late, we have become relatively obsessed regarding Prostate Cancer and give considerable attention concerning P Ca during the various stages of presentation. We as Urologists favour Radical Prostatectomy (now the preference is Robotic RP) as against other forms of treatment. A Radiation Oncologist will suggest RT in various avatars as against RP which we as Urologists cannot accept. We talk about the various toxicities associated with RT while the radiation Oncologists talk about the profound adverse events associated with RP. Recent articles on RT for P ca suggest that the long term results with RT is more or less same or even better when compared to RP. There are now some who mention that in most cases of P Ca, irrespective of stage, the appropriate definitive Treatments can be postponed by administration of ADT in the interim period.
The article I am providing is addressing the guidelines to be followed as regards RT in the era of COVID19.
If you peruse through the Guideline, many aspects mentioned can be accepted by Urologists as well in this era of COVID19 concerning treatment for P Ca.
Additionally, I am providing an Interview by Helen Moon with Samantha Kumar Pal and Sumeet K Bhanwadia on â€˜Early Stage Operable RCC in Covid19 Era.
I am providing the table attached to the first two articles which will explains to what are being highlighted in the articles.
With warm Regards,